v3.26.3
Segment Information
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
We have two reportable segments organized according to our products and services: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of aortic stent grafts, On-X®, surgical sealants, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita® Open NEO, E-vita Open Plus, Arcevo LSA, AMDSTM, the NEXUS ONETM, NEXUS DUOTM, and NEXUS TRETM aortic arch stent graft systems (the “NEXUS family of products”), and E-vita Thoracic 3G. Abdominal stent grafts include our E-xtra Design Engineering, E-nsideTM, ArtivexTM, E-tegraTM, E-ventusTM BX, TuvaTM BX, and E-liacTM products. Surgical sealants include BioGlue® Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues.
Our Chief Operating Decision Maker (“CODM”) is the Company’s Chairman, President, and CEO. The CODM reviews financial information to assess segment performance and determine how to allocate resources across segments.
The primary measure of segment performance, as assessed by our management, is segment gross margin or net external revenues less cost of products and preservation services. The CODM regularly reviews these costs, recognizing them as significant segment expenses. We do not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below.
The following table summarizes revenues, cost of products and preservation services, and gross margins for our reportable segments (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Revenues:
Medical devices$98,160 $87,665 $289,507 $253,907 
Preservation services25,630 25,723 76,377 71,431 
Total revenues123,790 113,388 365,884 325,338 
Cost of products and preservation services:
Medical devices35,701 27,811 99,389 81,389 
Preservation services12,112 11,182 34,553 32,865 
Total cost of products and preservation services47,813 38,993 133,942 114,254 
Gross margin:
Medical devices62,459 59,854 190,118 172,518 
Preservation services13,518 14,541 41,824 38,566 
Total gross margin$75,977 $74,395 $231,942 $211,084 
Net revenues by product were as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Products:
Aortic stent grafts$44,278$39,585$135,089$116,028
On-X30,31726,79786,77473,943
Surgical sealants18,94618,89357,03856,287
Other4,6192,39010,6067,649
Total products98,16087,665289,507253,907
Preservation services 25,63025,72376,37771,431
Total revenues$123,790$113,388$365,884$325,338